Back to search page

trbe20170814001

Technology to transfect DNA into cells in vivo without viral vectors

TECHNOLOGY PROFILE   REQUEST   ADD TO FAVOURITES
PRINT

 

ABSTRACT

A Belgian company is looking for a new method / product to transfect plasmid DNA into eukaryotic cells in vivo (in animals / human) without the use of viral vectors or apparatus. The method should work in muscle cells and other tissues. The company is able to perform research & development if the development is not finalized. Different kind of agreements; commercial agreement with technical support, license agreement or research agreement, can be considered depending on the level of developme


FULL DESCRIPTION

The aim of the method / product is to transfect plasmid DNA into cells in vivo and especially in muscle cells without the use of viral vectors and without using a specific apparatus (as an electroporator). The product can be a recombinant protein, chemical product... It should not be toxic since it is planned to use it in vivo (including humans). Production costs should be reduced in order to be competitive compared to the production of viral vectors. The method should be compatible with usual method of injections. If development is not finalized, the company can perform additional tests and R&D (alone or in collaboration). Commercial agreement with technical support, license agreement or research agreement can be considered.


Partner expertise sought:

- Type of partner sought: Expertise / knowledge in production of small quantities of the product is sought.
Patent, patent pending or possibility to file a patent to cover the product / method is also sought.
- Specific area of activity of the partner: Academic partner or research organization is sought. The partner could be able to provide first proof of concept and help in the development / industrial production.

Sign-in or create an account

To express an interest in this profile, you must first sign in or create a new account.

If you already have an account, sign in here

Not got an account yet, sign up here

KEY INFORMATION

Country of origin
BELGIUM
Profile date
18/09/2017
Deadline
18/09/2018

PARTNERSHIP(S) SOUGHT

License agreement Commercial agreement with technical assistance Research cooperation agreement

CLASSIFICATIONS

INDUSTRY SECTORS
Nanotechnology & Nanoscience \ Life Sciences \ Biosciences and Health \ Environment & Protecting Man \ Drug Discovery and Drug Development \ Diagnostics \ Medical Devices
TECHNOLOGY KEYWORDS
BIOLOGICAL SCIENCES / Medicine, Human Health / Gene - DNA Therapy / BIOLOGICAL SCIENCES / Medicine, Human Health / Stem cell Technologies / BIOLOGICAL SCIENCES / Biology / Biotechnology / Biochemistry / Biophysics / BIOLOGICAL SCIENCES / Biology / Biotechnology / Cellular and Molecular Biology / BIOLOGICAL SCIENCES / Micro- and Nanotechnology related to Biological sciences
COMMERCIAL KEYWORDS
Research and experimental development on biotechnology
MARKET KEYWORDS
GENETIC ENGINEERING/MOLECULAR BIOLOGY / Recombinant DNA / Medical genetic engineering applications / GENETIC ENGINEERING/MOLECULAR BIOLOGY / Biochemistry / Biophysics / GENETIC ENGINEERING/MOLECULAR BIOLOGY / Cellular and Molecular Biology / GENETIC ENGINEERING/MOLECULAR BIOLOGY / Genetic Engineering / GENETIC ENGINEERING/MOLECULAR BIOLOGY / Micro- and Nanotechnology related to Biological sciences

FIND OUT MORE

Contact Enterprise Europe Network Scotland by email at info@enterprise-europe-scotland.com, quoting reference number trbe20170814001